Commentary: Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system. [PDF]
Price MZ, Price RL.
europepmc +1 more source
ABSTRACT Aim To critically reflect on a transnational, clinically embedded doctoral journey undertaken during and after the COVID‐19 pandemic, and to draw conceptual and systemic lessons for doctoral education and clinical academic nursing pathways. Background Reflective accounts of doctoral study exist, yet few examine practice‐based PhDs conducted ...
Gideon U. Johnson
wiley +1 more source
Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom? [PDF]
Correll CU, Rubio JM, Kane JM.
europepmc +1 more source
Alternatives to antipsychotic medication: psychological approaches in managing psychological and behavioural distress in people with dementia [PDF]
Brechin, Donald +3 more
core +1 more source
ABSTRACT Background Patient mental state deterioration presents significant challenges in acute hospital settings, affecting outcomes, increasing reliance on restrictive interventions, and placing additional strain on healthcare staff. Despite its prevalence, consensus on best practice remains limited.
Tendayi Bruce Dziruni +3 more
wiley +1 more source
Clinical Outcomes and Factors Associated with Neuroleptic Malignant Syndrome in Older Patients: A Case Control Study. [PDF]
Pewloungsawat P +2 more
europepmc +1 more source
Prescribing and deprescribing of atypical antipsychotics in older multimorbid patients. [PDF]
Schneider C +8 more
europepmc +1 more source
A description of antipsychotic prescribing patterns on the inpatient behavioral health setting: a multicenter cross-sectional analysis. [PDF]
Maestri T, Anderson D, Echeverri M.
europepmc +1 more source
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials. [PDF]
Anand R +5 more
europepmc +1 more source
Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study. [PDF]
Šafářová N +5 more
europepmc +1 more source

